Document type
Book partVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/128109
Development of hybrid compounds to tackle Alzheimer’s disease
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Alzheimer’s disease (AD) is the main neurodegenerative disorder worldwide. Its pathogenesis involves a network where various mechanisms are interconnected. This complex pathological network makes it extremely challenging to find an efficacious treatment. Herein, we give an overview on the design of the so-called multi-target-directed ligands, i.e. compounds that concurrently hit several key pathogenic factors within the network, as a realistic option to tackle AD, with a particular emphasis on some structural classes of multitarget hybrids recently developed in our group.
Description
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/128014
Subject (English)
Citation
Citation
MUÑOZ-TORRERO LÓPEZ-IBARRA, Diego and PÉREZ AREALES, Francisco Javier. Development of hybrid compounds to tackle Alzheimer’s disease. Recent Advances in Pharmaceutical Sciences VIII. 2018. Vol. Editors: Diego Muñoz-Torrero, num. ISBN: 978-81-308-0579-5, pags. 43-58. [consulted: 8 of August of 2026]. Available at: https://hdl.handle.net/2445/128109